Execs Plead Guilty to Pharma Stock Insider-Trading

Source: pharmamanufacturing.com

Oct 10, 2013


John Lazorchak, A former director at biotech drugmaker Celgene Corp., pleaded guilty for his role in a health-care stock insider-trading ring that prosecutors said generated $1.48 million in illicit profit.

Lazorchak admitted to passing inside tips about Celgene’s planned acquisitions, quarterly earnings and drug approval developments to a former supervisor at Sanofi-Aventis as well as some high school friends.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments